
WEIGHT: 62 kg
Breast: DD
1 HOUR:100$
Overnight: +80$
Services: Ass licking, For family couples, Humiliation (giving), Massage prostate, Sauna / Bath Houses
Official websites use. Share sensitive information only on official, secure websites. Email: romain. Patients with substance use disorders present with many risk factors for liver disease—including alcohol, hepatitis C virus infection, and obesity—and should thus be screened for compensated advanced chronic liver disease cACLD.
Such screening could potentially be performed by outpatient addiction clinics. The screening was proposed during the patient's routine care and was performed immediately after the scheduled consultation. Five patients 4. Patients' acceptance of the screening was associated with older age, being on one's own or professionally inactive, and presenting with alcohol use disorder. Overall, our results demonstrated that opportunistic cACLD screening using TE in outpatient addiction clinics was feasible and acceptable, with good results.
Keywords: addiction clinics, compensated advanced chronic liver disease, screening, transient elastography. Half of them accepted. Patients offered the procedure represented Opportunistic cACLD screening at an addiction clinic is acceptable and feasible in terms of staff involvement. Liver disease is an important public health concern worldwide.
Chronic liver diseases are asymptomatic for years, and progress from no fibrosis to severe fibrosis, and then compensated cirrhosis, before the occurrence of severe complications. The term compensated advanced chronic liver disease cACLD describes asymptomatic patients with either severe fibrosis or compensated cirrhosis, who are difficult to clinically identify de Franchis, This concept emerged from the availability of noninvasive diagnostic methods, such as liver stiffness measurement LSM by transient elastography TE , which shows very good performance in distinguishing between no or mild fibrosis and cACLD in most liver diseases Singh et al.
Thus, it is important to screen for cACLD in populations at risk of hepatic fibrosis. Patients with substance use disorders often receive outpatient care at addiction clinics, which could thus be appropriate settings for cACLD screening.